Edge Therapeutics
A biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Employees
Enterprise value
$224—336m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Merger | ||
| Total Funding | 000k | ||
Sofinnova(exited)
Franklin Advisors(exited)
New Leaf Venture Partners(exited)
BioMed Ventures(exited)
Janus Capital Group(exited)
Venrock(exited)
| EUR | 2017 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.